The International Myeloma Working Group (IMWG) emerged from the IMF’s Scientific Advisory Board which was established in 1995. It became clear that there was a need to conduct collaborative research and produce consensus guidelines for the myeloma community.The first consensus guideline was published in 2003 and the first Annual Brainstorming Summit was organized in Barcelona in 2010.
IMWG Mission Statement
The mission of the IMWG is to conduct collaborative basic, clinical, and translational research to improve outcomes for myeloma patients while providing scientifically validated, critically appraised consensus guidelines for the myeloma community globally.
The Importance of the IMWG
The IMWG is the most prestigious organization for myeloma researchers from around the world. The yearly IMWG Breakfast Meeting occurs at 6:30 a.m. during the American Society of Hematology annual conference. This breakfast is the most packed and sought after venue for myeloma practitioners to be informed and included in current and new research projects.
Creating, supporting, and hosting the important work of the IMWG and its members is a critical element of the International Myeloma Foundation’s mission to expand myeloma research and to educate multiple myeloma patients around the world.